Company Filing History:
Years Active: 1993
Title: Innovator Miriam Orevi: Advancing Medicine with Leech-Derived Solutions
Introduction: Miriam Orevi is a distinguished inventor based in Jerusalem, Israel. She is recognized for her significant contribution to medical science through her innovative research that has led to the development of a novel composition aimed at inhibiting blood platelet aggregation. This breakthrough offers promising therapeutic options for various clinical disorders.
Latest Patents: Miriam Orevi holds a patent titled "Platelet-aggregating inhibitory agents from leech saliva." This invention describes a composition of matter derived from the saliva of leeches belonging to the Hirudinidae family. The formulation is particularly useful as an inhibitor of blood platelet aggregation, which is vital in treating thrombotic, inflammatory, and immunological disorders. The composition consists of multiple components, each with molecular weights lower than 2,000 daltons, demonstrating inhibitory activity against platelet aggregation triggered by various agents, including Platelet Activating Factor-acether (PAF-acether), arachidonic acid, thrombin, ADP, and epinephrine.
Career Highlights: Miriam Orevi is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where she plays a crucial role in advancing her research and patent applications. Her work has not only contributed to scientific knowledge but also positions her as a significant figure in the domain of innovative medical therapies.
Collaborations: Throughout her career, Miriam has collaborated with esteemed colleagues, including Meir Rigbi and Amiram Eldor. These partnerships have fostered an environment of collaborative research, leading to advancements in therapeutic solutions in the medical field.
Conclusion: Miriam Orevi's pioneering work highlights the intersection of innovation and medicine. With her patent focusing on leech-derived agents for platelet aggregation inhibition, she exemplifies the impact of inventive thinking on healthcare solutions. Her contributions are a testament to the potential of research and innovation in addressing significant clinical challenges.